Skip to main content
. 2021 Jun 14;5(2):e1476. doi: 10.1002/cnr2.1476

FIGURE 2.

FIGURE 2

Kaplan–Meier curves for progression‐free survival (PFS) and overall survival (OS) for KRD (A; PFS, B; OS) and KD (C; PFS, D; OS) therapy, according to refractoriness to BTZ and/or LEN